CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats.
about
Future pharmacological treatments for substance use disordersPharmacotherapy of methamphetamine addiction: an updateA role for brain stress systems in addiction.The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid systemRole of cues and contexts on drug-seeking behaviourReduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addictionMitragynine attenuates withdrawal syndrome in morphine-withdrawn zebrafishRole of Corticotropin Releasing Factor 1 Signaling in Cocaine Seeking during Early Extinction in Female and Male RatsAugmented cocaine seeking in response to stress or CRF delivered into the ventral tegmental area following long-access self-administration is mediated by CRF receptor type 1 but not CRF receptor type 2CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behaviorExtended access cocaine self-administration differentially activates dorsal raphe and amygdala corticotropin-releasing factor systems in ratsStress-Induced Reinstatement of Drug Seeking: 20 Years of Progress.Epigenetics and memory: causes, consequences and treatments for post-traumatic stress disorder and addiction.Connecting the pathology of posttraumatic stress and substance use disorders: monoamines and neuropeptides.Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinenceStress modulation of drug self-administration: implications for addiction comorbidity with post-traumatic stress disorder.Prevention of social stress-escalated cocaine self-administration by CRF-R1 antagonist in the rat VTA.α(2) Adrenergic and imidazoline receptor agonists prevent cue-induced cocaine seeking.Adrenal activity during repeated long-access cocaine self-administration is required for later CRF-Induced and CRF-dependent stressor-induced reinstatement in rats.Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention.The locus coeruleus: A key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse.Progress in corticotropin-releasing factor-1 antagonist development.Repeated stimulation of CRF receptors in the BNST of rats selectively induces social but not panic-like anxiety.The role of CRF and CRF-related peptides in the dark side of addiction.Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking.Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor.Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapseEffect of cafeteria diet history on cue-, pellet-priming-, and stress-induced reinstatement of food seeking in female rats.Anti-relapse medications: preclinical models for drug addiction treatment.The reinstatement model and relapse prevention: a clinical perspective.Role of bed nucleus of the stria terminalis corticotrophin-releasing factor receptors in frustration stress-induced binge-like palatable food consumption in female rats with a history of food restriction.Involvement of noradrenergic neurotransmission in the stress- but not cocaine-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: role for β-2 adrenergic receptors.Individual differences in prefrontal cortex function and the transition from drug use to drug dependenceTherapeutic potential of CRF receptor antagonists: a gut-brain perspective.Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.Corticotropin releasing factor: a key role in the neurobiology of addictionNeurobiology of addiction: a neurocircuitry analysis.Potential uses of corticotropin-releasing hormone antagonists.Interaction between glucocorticoid hormones, stress and psychostimulant drugs.The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF1 receptors.
P2860
Q22242633-C1C8BE8B-ABAB-4D64-BACF-B0C5AC6DE8F3Q24648913-273B7C2B-EC35-4971-B645-B8D87CEC0135Q24649537-25B29A44-8325-4B74-9DB2-1B844C1FE1E0Q24655164-A0FC5748-6011-4499-9AA9-2BB5395C1CE8Q26825476-C36A25DA-45C3-41DB-9845-3A93386B2B30Q28363073-BC713F52-6D5D-4B95-828A-CD1F17542657Q28478509-CD02E1A6-F1F8-4739-8D24-F65BBAEC1DB8Q28552258-4699341A-1362-417E-AF45-1760CD6BAAB7Q28573866-1823AE4B-2840-4A94-9236-778CF717FC76Q28580222-C3E27B12-032A-4F70-BBCD-9D2BD2F66345Q28582150-06CD95E4-6DD8-4D9D-9E6F-AF84F0F72568Q30366964-8D15EDCC-FDD9-4152-98AF-7FB74B981EEEQ30394729-090FE158-DA29-47A8-9D1E-63499A25B222Q30419977-8C1FBEB7-EF9E-457A-8187-DA5BFA490042Q30455336-14A08AD0-DFA2-453E-9AE5-2A49F76EDAAFQ30458743-A7F5F3A9-AE06-4A42-9469-2A9E85082174Q30461988-BCFC9269-630E-4A48-8F32-C23BA8566F63Q30462473-1FB78307-CA60-4F55-B1A0-00D46319A669Q30467194-CC4055BF-BDC1-442D-8418-6D4457671423Q30468942-D7A399B1-C16B-4669-93AF-D23687038EA4Q30470629-E3B3B03A-6DE3-4D6B-B4ED-99DF0438CB9DQ30475627-A233E8A9-7CBC-4815-A49F-93CC77147184Q30476186-711C53AC-DB2D-4717-A4F4-4FC0434D7818Q30476985-B0025F76-FD40-4B16-9268-FEDB1782BBF6Q30501299-D60FB379-903C-401C-A99E-4A08D7B3E20EQ33616639-2EEEC41F-A5C5-422B-BDB8-A4BEF5C2D7D0Q33656596-BD630D68-4469-49F9-8729-4A3417B644BBQ33904085-2D0A26F9-A93A-44C5-9AD9-7A11C5FE985AQ33927470-E8E7E07C-571D-467F-8A24-1AFFBD165064Q34062912-9C1A2F98-7DD3-4B5C-8B8F-70364DA9048AQ34067338-70B31C2E-BA0D-4766-A8B6-563B41172900Q34130038-91B85205-6CAA-4527-BBFA-01704C6290AFQ34203887-ACB24EB3-FBFF-467A-8AAB-611BD5342071Q34204338-374E05D1-750A-42B6-841C-2DBAD85A8976Q34320180-549A5CEA-B04E-49E4-A0D6-73288AAB1F99Q34421204-10523B1A-B017-4D62-A56E-481D15269DB7Q34535855-3DF5363E-54F6-4DCA-8284-41FFC87A20F0Q34587976-088B3E22-972A-41F7-B324-D95D3EA3F287Q34794541-FDE90E8F-6DB1-4504-80B1-745F348860F4Q35039457-2C2C9B93-ED8D-4B81-86E9-01765E493DFD
P2860
CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
CP-154,526, a selective, non-p ...... aine- and heroin-trained rats.
@en
CP-154,526, a selective, non-p ...... aine- and heroin-trained rats.
@nl
type
label
CP-154,526, a selective, non-p ...... aine- and heroin-trained rats.
@en
CP-154,526, a selective, non-p ...... aine- and heroin-trained rats.
@nl
prefLabel
CP-154,526, a selective, non-p ...... aine- and heroin-trained rats.
@en
CP-154,526, a selective, non-p ...... aine- and heroin-trained rats.
@nl
P2093
P356
P1433
P1476
CP-154,526, a selective, non-p ...... aine- and heroin-trained rats.
@en
P2093
P2888
P304
P356
10.1007/S002130050608
P577
1998-05-01T00:00:00Z